TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, ophthalmic, and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types; TRC205 created for the treatment of fibrotic diseases; and TRC102, a small molecule that is in clinical development made for...
KEEP ON STRONG WATCH FOR A BREAKOUT ON CONTINUATION AFTER A SEVERAL STRONG TRADING SESSIONS. ALERT SET FOR BREAK OF $.91 FOR PROJECTED TARGET OF $1.30. SPECULATIVE AND RISKY.
AVERAGE ANALYSTS PRICE TARGET $1.50
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted...
keeping it simple!
We have seemed to reach the bottom 2$ mark once again, and have indicators of a bounce to the top of the wedge, and possible breakout!
I see the moku cloud turning bullish slightly, and buy signals in this area firing.
We had a weekly sqeeze fire short, which seems to be slowing down right about now, with noticable increased volume over the...